S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
3 Overdone Selloffs Offering a Second Chance
pixel
By slimmest of margins, Senate takes up $1.9T relief bill
Powell: Higher inflation temporary, no rate hikes in sight
Tech pulls stocks lower as bond yields continue upward march
EXPLAINER: Why rising rates are unsettling Wall Street
Shares slip in Asia after bond yield spike hits Wall St
Stocks turn lower as bond yields continue their upward march
pixel
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
3 Overdone Selloffs Offering a Second Chance
pixel
By slimmest of margins, Senate takes up $1.9T relief bill
Powell: Higher inflation temporary, no rate hikes in sight
Tech pulls stocks lower as bond yields continue upward march
EXPLAINER: Why rising rates are unsettling Wall Street
Shares slip in Asia after bond yield spike hits Wall St
Stocks turn lower as bond yields continue their upward march
pixel
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
3 Overdone Selloffs Offering a Second Chance
pixel
By slimmest of margins, Senate takes up $1.9T relief bill
Powell: Higher inflation temporary, no rate hikes in sight
Tech pulls stocks lower as bond yields continue upward march
EXPLAINER: Why rising rates are unsettling Wall Street
Shares slip in Asia after bond yield spike hits Wall St
Stocks turn lower as bond yields continue their upward march
pixel
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
3 Overdone Selloffs Offering a Second Chance
pixel
By slimmest of margins, Senate takes up $1.9T relief bill
Powell: Higher inflation temporary, no rate hikes in sight
Tech pulls stocks lower as bond yields continue upward march
EXPLAINER: Why rising rates are unsettling Wall Street
Shares slip in Asia after bond yield spike hits Wall St
Stocks turn lower as bond yields continue their upward march
pixel
Log in
NASDAQ:VTGN

VistaGen Therapeutics Earnings Date, Estimates & History

$2.20
-0.12 (-5.17 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.00
Now: $2.20▼
$2.29
50-Day Range
$1.89
MA: $2.25▼
$2.96
52-Week Range
$0.30
Now: $2.20▼
$3.18
Volume3.58 million shs
Average Volume4.67 million shs
Market Capitalization$311.73 million
P/E RatioN/A
Dividend YieldN/A
Beta0.52

Earnings

VistaGen Therapeutics (NASDAQ:VTGN) Earnings Information

VistaGen Therapeutics last posted its earnings results on February 11th, 2021. The reported ($0.07) EPS for the quarter, missing analysts' consensus estimates of ($0.05) by $0.02. The company earned $0.31 million during the quarter, compared to the consensus estimate of $0.33 million. VistaGen Therapeutics has generated ($0.50) earnings per share over the last year. VistaGen Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 5th, 2021 based off prior year's report dates.

VistaGen Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VistaGen Therapeutics (NASDAQ:VTGN) Earnings Estimates

2021 EPS Consensus Estimate: ($0.29)
2022 EPS Consensus Estimate: ($0.27)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.10)($0.10)($0.10)
Q2 20211($0.10)($0.10)($0.10)
Q3 20211($0.05)($0.05)($0.05)
Q4 20212($0.04)($0.04)($0.04)
Q1 20222($0.05)($0.05)($0.05)
Q2 20222($0.06)($0.05)($0.06)
Q3 20222($0.11)($0.06)($0.09)
Q4 20222($0.10)($0.06)($0.08)

VistaGen Therapeutics (NASDAQ VTGN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
7/5/2021
(Estimated)		       
2/11/202112/31/2020($0.05)($0.07)($0.07)$0.33 million$0.31 millionN/A
11/12/20209/30/2020($0.02)($0.05)($0.05)$5.00 million$0.33 millionListen
8/13/2020Q1 2021($0.07)($0.07)($0.07)N/A
6/29/2020Q4($0.08)($0.07)($0.13)N/A
2/13/2020Q3 2020($0.07)($0.15)($0.15)N/A
11/7/2019Q2($0.1350)($0.13)($0.13)N/A
8/16/2019Q1 2020($0.15)($0.15)N/A
6/25/2019Q4 2019($0.15)($0.15)N/A
2/12/2019Q3 2019($0.2150)($0.2450)($0.24)N/A
10/29/20189/30/2018($0.17)($0.30)($0.30)N/A
8/14/2018Q1 2019($0.14)($0.1950)($0.20)N/A
6/26/2018Q4 2018($0.28)($0.19)($0.19)N/A
2/12/2018Q3 2018($0.24)($0.23)N/A
11/9/2017Q2 2018($0.48)($0.53)($0.53)N/A
8/14/2017Q1 2018($0.28)($0.28)N/A
6/29/2017Q4 2017($0.32)($0.32)N/A
2/13/2017Q3 2017($0.34)($0.34)$1.25 millionN/A
11/14/2016Q2 2017($0.42)($0.42)N/A
8/12/2016Q1 2017($0.51)($0.51)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/5/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.